Search
for
Sort by
Research 30 of 1000+
- 1449 PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY
- Finasteride-its impact on sexual function and prostate cancer
- Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men
- Male alopecia, finasteride, and cancer risk
- Two cases of low-prostate-specific antigen localized prostate cancer incidentally detected by computed tomography
- Propecia: The Goose That Lays the Golden Eggs
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- A new look at an old option in the treatment of early-stage prostate cancer: hormone therapy as an alternative to watchful waiting
- A cornerstone of hematological science
- Regarding prostate-specific antigen: let's not shoot the messenger
- Ductal breast cancer in a male patient
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- S87 Image guided radiotherapy (IGRT) in stage III prostate cancer: analysis of acute toxicity
- Level-1 Data From the REDUCE Study and the PCPT Data
- The finasteride riddle
- Synopsis: 2005 Annual Meeting of the American Society of Andrology
- Finasteride
- Proscar and Propecia—A Therapeutic Perspective
- Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Finasteride Doesn't Shorten Survival in Long-term Study
- Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Five-alpha-reductase Inhibitors for prostate cancer prevention.